Development of Monoclonal Antibodies to Prevent and Treat Infections from Filo-, Nairo-, Phenui-, Picorna- and Toga Viruses

Programme: Horizon Europe (HORIZON) – Cluster 1: Health
Topic Code: HORIZON-HLTH-2027-01-DISEASE-07
Type of Action: Research and Innovation Action (RIA)
Funding Type: Horizon Europe Grant Funding
Opening Date: 10 February 2027
Closing Date: 13 April 2027 (17:00 Brussels Time)

The European Commission

Africa Business Accelerator 2026: 8-Week Growth Programme for Ambitious African SMEs and Founders

Applications are now open for the Africa Business Accelerator (ABA) 2026, the flagship growth programme of the Africa SME Assembly designed to help African founders build stronger, more scalable, and investment-ready businesses.

The Africa Business Accelerator was established to address one of the

Merck Research Grants 2026: Up to €500,000 per Year for Innovative Scientific Research

Applications are now open for the Merck Research Grants 2026 programme, a global research funding initiative designed to support innovative scientific research with strong potential for future impact and industry collaboration.

Since 2018, Merck has awarded research grants to scientists and research